Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
ALLEN, Texas, March 13, 2017 -- Atrion Corporation (NASDAQ:ATRI) today announced the election of Preston G. Athey as a director effective immediately. Mr. Athey recently retired after an extraordinary 38 year career with T. Rowe Price Associates. In 1991, he began managing the firm's Small-Cap Value Fund. Under his tutelage, fund assets grew from $45 million to $10 billion. Mr. Athey holds a BA degree from Yale University and an MBA degree from Stanford University. Mr. Athey brings a wealth of financial and operational experience, and will be another strong voice for our stockholders.
Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.
Contact: Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800
